BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 22343687)

  • 21. Do coagulation screening tests detect increased generation of thrombin and plasmin in sick newborn infants?
    Schmidt B; Vegh P; Johnston M; Andrew M; Weitz J
    Thromb Haemost; 1993 May; 69(5):418-21. PubMed ID: 8322263
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fibrin monomer complex in normal pregnant women: a potential thrombotic marker in pregnancy.
    Onishi H; Kaniyu K; Iwashita M; Tanaka A; Watanabe T
    Ann Clin Biochem; 2007 Sep; 44(Pt 5):449-54. PubMed ID: 17761030
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prospective evaluation of hemostatic system activation and thrombin potential in healthy pregnant women with and without factor V Leiden.
    Eichinger S; Weltermann A; Philipp K; Hafner E; Kaider A; Kittl EM; Brenner B; Mannhalter C; Lechner K; Kyrle PA
    Thromb Haemost; 1999 Oct; 82(4):1232-6. PubMed ID: 10544904
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Predictive value of coagulative molecular markers for thromboembolism in patients with nonvalvular atrial fibrillation: prospective five-year follow-up study].
    Enta K; Iwade K; Aosaki M; Uchida T; Kasanuki H
    J Cardiol; 2004 Dec; 44(6):223-32. PubMed ID: 15638220
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Soluble fibrin is not excreted in urine and its plasma level is elevated in nephrotic syndrome].
    Morikawa T; Yamashiro Y; Okano K; Kasamatsu M; Sugai H; Kitamura H; Ohba I; Hotta O; Taguma Y; Sakurai J; Kitamoto Y
    Rinsho Byori; 2009 Apr; 57(4):319-23. PubMed ID: 19489432
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Influence of aging on the activity of the hemostatic system: prothrombin fragment 1+2, thrombin-antithrombin III complexes and D-dimers in 80 healthy subjects with age ranging from 20 to 94 years.
    Cadroy Y; Pierrejean D; Fontan B; Sié P; Boneu B
    Nouv Rev Fr Hematol (1978); 1992; 34(1):43-6. PubMed ID: 1523099
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Thrombin generation and fibrinolysis in the thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome.
    Monteagudo J; Pereira A; Reverter JC; Pijoan J; Tusell J; Puig L; Ordinas A; Castillo R
    Thromb Haemost; 1991 Nov; 66(5):515-9. PubMed ID: 1803613
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hypercoagulability in overweight and obese subjects who are asymptomatic for thrombotic events.
    Campello E; Zabeo E; Radu CM; Spiezia L; Gavasso S; Fadin M; Woodhams B; Vettor R; Simioni P
    Thromb Haemost; 2015 Jan; 113(1):85-96. PubMed ID: 25318550
    [TBL] [Abstract][Full Text] [Related]  

  • 29. D-dimer and TAT measurement in patients with deep venous thrombosis: utility in diagnosis and judgement of anticoagulant treatment effectiveness.
    Speiser W; Mallek R; Koppensteiner R; Stümpflen A; Kapiotis S; Minar E; Ehringer H; Lechner K
    Thromb Haemost; 1990 Oct; 64(2):196-201. PubMed ID: 2125371
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of markers of coagulation activation and thrombin generation test in uncomplicated pregnancies.
    Joly B; Barbay V; Borg JY; Le Cam-Duchez V
    Thromb Res; 2013 Sep; 132(3):386-91. PubMed ID: 23962423
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Thrombophilic variables do not increase the generation or procoagulant activity of thrombin during cardiopulmonary bypass.
    Raivio P; Petäjä J; Kuitunen A; Lassila R
    Ann Thorac Surg; 2008 Feb; 85(2):536-42. PubMed ID: 18222259
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognostic values of the factor Xa-activated clotting time and endogenous thrombin potential in patients suspected of having disseminated intravascular coagulation.
    Seo JW; Kim HK; Kim JE; Park S; Cho HI
    Thromb Res; 2009 Feb; 123(4):565-72. PubMed ID: 18479738
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Thrombin generation, thrombin-antithrombin complex, and prothrombin fragment F1+2 as biomarkers for hypercoagulability in cancer patients.
    Lundbech M; Krag AE; Christensen TD; Hvas AM
    Thromb Res; 2020 Feb; 186():80-85. PubMed ID: 31918352
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Changes in molecular markers of hemostatic and fibrinolytic activation under various sampling conditions using vacuum tube samples from healthy volunteers.
    Omote M; Asakura H; Takamichi S; Shibayama M; Yoshida T; Kadohira Y; Maekawa M; Yamazaki M; Morishita E; Nakao S; Wada T
    Thromb Res; 2008; 123(2):390-5. PubMed ID: 18579183
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reduction of pain episodes and prothrombotic activity in sickle cell disease by dietary n-3 fatty acids.
    Tomer A; Kasey S; Connor WE; Clark S; Harker LA; Eckman JR
    Thromb Haemost; 2001 Jun; 85(6):966-74. PubMed ID: 11434703
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Activation of the coagulation cascade in patients with leptospirosis.
    Chierakul W; Tientadakul P; Suputtamongkol Y; Wuthiekanun V; Phimda K; Limpaiboon R; Opartkiattikul N; White NJ; Peacock SJ; Day NP
    Clin Infect Dis; 2008 Jan; 46(2):254-60. PubMed ID: 18171258
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Coagulation activation and microparticle-associated coagulant activity in cancer patients. An exploratory prospective study.
    van Doormaal F; Kleinjan A; Berckmans RJ; Mackman N; Manly D; Kamphuisen PW; Richel DJ; Büller HR; Sturk A; Nieuwland R
    Thromb Haemost; 2012 Jul; 108(1):160-5. PubMed ID: 22535219
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Thrombin generation and cell-dependent hypercoagulability in sickle cell disease.
    Whelihan MF; Lim MY; Mooberry MJ; Piegore MG; Ilich A; Wogu A; Cai J; Monroe DM; Ataga KI; Mann KG; Key NS
    J Thromb Haemost; 2016 Oct; 14(10):1941-1952. PubMed ID: 27430959
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Intracranial hemorrhage and hemostasis. Monitoring patients after intracranial hemorrhage by determination and follow-up of activation products of blood coagulation].
    Menges T; von Lessen A; Welters I; Wagner RM; Ruwoldt R; Boldt J; Hempelmann G
    Infusionsther Transfusionsmed; 1994 Aug; 21(4):244-50. PubMed ID: 7950289
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Plasma markers of hypercoagulability in patients with serious infections and risk of septic shock.
    Psuja P; Zozulińska M; Turowiecka Z; Cieślikowski W; Vinazzer H; Zawilska K
    Clin Appl Thromb Hemost; 2002 Jul; 8(3):225-30. PubMed ID: 12361199
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.